Tracy Liu sold $2.9M of ACMR
director at ACM Research, Inc.. 60,000 shares at an average of $47.51, traded Mar 10, 2026, filed Mar 12, 2026.
Score components
- +15RoleDirector
- +25Trade size$2.9M at market
- +10Share of holdings soldSold 39% of holdings
- +15Cluster6 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001140361-26-009239, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 10, 2026 | MOption exercise Class A Common Stock10b5-1 | +45,000 | $1.00 | $45k | 155,772 | Mar 12, 2026 |
| Mar 10, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -32,216 | $47.06 | $1.5M | 123,556 | Mar 12, 2026 |
| Mar 10, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -12,784 | $48.19 | $616k | 110,772 | Mar 12, 2026 |
| Mar 11, 2026 | MOption exercise Class A Common Stock10b5-1 | +15,000 | $1.00 | $15k | 125,772 | Mar 12, 2026 |
| Mar 11, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -11,623 | $47.81 | $556k | 114,149 | Mar 12, 2026 |
| Mar 11, 2026 | SOpen-market sale Class A Common Stock10b5-1 | -3,377 | $48.25 | $163k | 110,772 | Mar 12, 2026 |
| Mar 10, 2026 | MOption exercise Stock Optionderivative10b5-1 | -45,000 | $0.00 | $0 | 15,000 | Mar 12, 2026 |
| Mar 11, 2026 | MOption exercise Stock Optionderivative10b5-1 | -15,000 | $0.00 | $0 | 0 | Mar 12, 2026 |
Related signals
Other insiders at ACM Research, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 10Weak | ACM Research, Inc. | David H Wang See Remarks | $11M 140,000 shares | -16% | |
| 25Weak | ACM Research, Inc. | David H Wang See Remarks | $5.2M 110,000 shares | -13% | |
| 40Moderate | ACM Research, Inc. | Mark McKechnie See Remarks | $4.5M 98,551 shares | -162% | |
| 27Weak | ACM Research, Inc. | Haiping Dun director | $217k 5,000 shares | -100% | |
| 30Weak | ACM Research, Inc. | Lisa Feng See remarks | $1.4M 30,000 shares | -46% | |
| 28Weak | ACM Research, Inc. | Charles C Pappis director | $250k 5,000 shares | -100% | |
| 40Moderate | ACM Research, Inc. | Mark McKechnie See Remarks | $1.1M 31,250 shares | -324% | |
| 25Weak | ACM Research, Inc. | David H Wang See Remarks | $4.4M 130,000 shares | -15% | |
| 40Moderate | ACM Research, Inc. | Fuping Chen See remarks | $4.0M 120,000 shares | -120% | |
| 15Weak | ACM Research, Inc. | Lisa Feng See remarks | $998k 30,000 shares | -46% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.